Wexford Capital »

Adicet Bio shares owned by Wexford Capital

Quarter-by-quarter ownership of Adicet Bio (ACET) shares owned by Wexford Capital from 13F filings

Historical chart of Wexford Capital investment in Adicet Bio

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio held by Wexford Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio by Wexford Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $28k 15k 1.89

More positions owned by Wexford Capital

Mammoth Energy Svcs (TUSK)
International Seaways (INSW)
Nephros (NEPH)
Ishares Msci Aust Etf (EWA)
Ishares Msci Cda Etf (EWC)
Spdr Ser Tr Portfolio S&p600 (SPSM)
Cenovus Energy (CVE)
Stellantis SHS (STLA)
Cool Common Shares (CLCO)
Astrazeneca Sponsored Adr (AZN)
Silverbow Resources (SBOW)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Gold Tr Gold Shs (GLD)
Golar Lng SHS (GLNG)
Enterprise Products Partners (EPD)

View all positions for Wexford Capital

Top funds holding Adicet Bio

OrbiMed Advisors
Cowen And Company
Carlyle
Vanguard Group
Millennium Management
Tang Capital Management
Two Sigma Advisers
Norges Bank Investment Management
Two Sigma Investments
D. E. Shaw & Co
Schonfeld Strategic Advisors
Dimensional Fund Advisors
Citadel Advisors
Bank of New York Mellon
Exchange Traded Concepts

View all funds holding Adicet Bio